Published on Medical Design Technology (http://www.mdtmag.com)

Home > Concert Pharmaceuticals names Roessel, Sabounjian to exec roles

Concert Pharmaceuticals names Roessel, Sabounjian to exec roles

Mass High Tech: The Journal of New England Technology

Concert Pharmaceuticals Inc. has made two new executive appointments to grow its development work. Mark Roessel has been named vice president of regulatory affairs and quality assurance, while LuAnn Sabounjian has been appointed vice president of clinical operations.

Roessel previously served in similar roles, most recently as vice president of regulatory affairs at Indevus Pharmaceuticals Inc., which has since been bought by Endo Pharmaceuticals Inc. [1]  Before that, he was VP regulatory affairs and quality assurance at AMAG Pharmaceuticals Inc.

SOURCE [2]

Source URL (retrieved on 06/19/2013 - 5:05pm): http://www.mdtmag.com/news/2011/04/concert-pharmaceuticals-names-roessel-sabounjian-exec-roles

Links:
[1] http://www.masshightech.com/stories/2009/03/09/daily29-Indevus-finalizes-637M-buyout.html
[2] http://www.masshightech.com/stories/2011/04/11/daily27-Concert-Pharmaceuticals-names-Roessel-Sabounjian-to-exec-roles.html